Claire L Donohoe1, Erin McGillycuddy, John V Reynolds. 1. Department of Surgery, Trinity College Dublin/St James' Hospital, Trinity Centre for Health Sciences, St James' Hospital, Dublin 8, Ireland.
Abstract
BACKGROUND: Health-related quality of life (HRQL) has been studied extensively during the first year following esophagectomy, but little is known about HRQL in long-term survivors. The aim of this study was to investigate HRQL in patients alive at least 1 year after surgical resection for esophageal cancer using validated European Organisation for Research and Treatment of Cancer (EORTC) quality of life (QOL) questionnaires (QLQ). METHODS: Eligible patients, without known disease recurrence and at least 1 year after esophagectomy, were identified from a prospectively maintained database. Patients completed general (QLQ-C30) and esophageal cancer-specific (QLQ-OES18, OG25) questionnaires. A numeric score (0-100) was computed in each conceptual area and compared with validated cancer (n = 1031) and age-matched (n = 7802) healthy populations using two-tailed unpaired t-tests. A cohort of 80 patients had pretreatment scores recorded. RESULTS: Altogether, 132 of 156 eligible patients (84%) completed the self-rated questionnaire, 105 (67.3%) were men, and the mean age was 62 years (range 29-84 years). The mean time since esophagectomy was 70.3 months (12-299 months). Global health status was significantly reduced at least 1 year after esophagectomy (mean ± SD score 48.4 ± 18.6) when compared with patients with esophageal cancer prior to treatment (55.6 ± 24.1) and the general population (71.2 ± 22.4) (p < 0.0001). In a prospective cohort of eighty patients, symptoms related to swallowing difficulty, reflux, pain, and coughing significantly decreased in the long term (p < 0.0001). The degree of subjective swallowing dysfunction was highly correlated with a poor QOL (Spearman's ρ = 0.508, p < 0.01). CONCLUSIONS: Global health status remains significantly reduced in long-term survivors after esophagectomy compared with population controls, and swallowing dysfunction is highly associated with this compromised QOL.
BACKGROUND: Health-related quality of life (HRQL) has been studied extensively during the first year following esophagectomy, but little is known about HRQL in long-term survivors. The aim of this study was to investigate HRQL in patients alive at least 1 year after surgical resection for esophageal cancer using validated European Organisation for Research and Treatment of Cancer (EORTC) quality of life (QOL) questionnaires (QLQ). METHODS: Eligible patients, without known disease recurrence and at least 1 year after esophagectomy, were identified from a prospectively maintained database. Patients completed general (QLQ-C30) and esophageal cancer-specific (QLQ-OES18, OG25) questionnaires. A numeric score (0-100) was computed in each conceptual area and compared with validated cancer (n = 1031) and age-matched (n = 7802) healthy populations using two-tailed unpaired t-tests. A cohort of 80 patients had pretreatment scores recorded. RESULTS: Altogether, 132 of 156 eligible patients (84%) completed the self-rated questionnaire, 105 (67.3%) were men, and the mean age was 62 years (range 29-84 years). The mean time since esophagectomy was 70.3 months (12-299 months). Global health status was significantly reduced at least 1 year after esophagectomy (mean ± SD score 48.4 ± 18.6) when compared with patients with esophageal cancer prior to treatment (55.6 ± 24.1) and the general population (71.2 ± 22.4) (p < 0.0001). In a prospective cohort of eighty patients, symptoms related to swallowing difficulty, reflux, pain, and coughing significantly decreased in the long term (p < 0.0001). The degree of subjective swallowing dysfunction was highly correlated with a poor QOL (Spearman's ρ = 0.508, p < 0.01). CONCLUSIONS: Global health status remains significantly reduced in long-term survivors after esophagectomy compared with population controls, and swallowing dysfunction is highly associated with this compromised QOL.
Authors: Therese Djärv; Chris Metcalfe; Kerry N L Avery; Pernilla Lagergren; Jane M Blazeby Journal: J Clin Oncol Date: 2010-03-01 Impact factor: 44.544
Authors: James D Luketich; Miguel Alvelo-Rivera; Percival O Buenaventura; Neil A Christie; James S McCaughan; Virginia R Litle; Philip R Schauer; John M Close; Hiran C Fernando Journal: Ann Surg Date: 2003-10 Impact factor: 12.969
Authors: J C Clifton; R J Finley; G Gelfand; A J Graham; R Inculet; R Malthaner; L Tan; J Lim; J Singer; C Lovato Journal: Dis Esophagus Date: 2007 Impact factor: 3.429
Authors: J M O'Riordan; O N Tucker; P J Byrne; G S A McDonald; N Ravi; P W N Keeling; J V Reynolds Journal: Am J Gastroenterol Date: 2004-02 Impact factor: 10.864
Authors: Christian A Gutschow; Arnulf H Hölscher; Jessica Leers; Hans Fuchs; Marc Bludau; Klaus L Prenzel; E Bollschweiler; Wolfgang Schröder Journal: Langenbecks Arch Surg Date: 2012-06-04 Impact factor: 3.445
Authors: Silvio Däster; Savas D Soysal; Lea Stoll; Ralph Peterli; Markus von Flüe; Christoph Ackermann Journal: World J Surg Date: 2014-09 Impact factor: 3.352
Authors: Hans Fuchs; Arnulf H Hölscher; Jessica Leers; Marc Bludau; Sebastian Brinkmann; Wolfgang Schröder; Hakan Alakus; Stefan Mönig; Christian A Gutschow Journal: Gastric Cancer Date: 2015-01-28 Impact factor: 7.370
Authors: Emer M Guinan; Suzanne L Doyle; Linda O'Neill; Margaret R Dunne; Emma K Foley; Jacintha O'Sullivan; John V Reynolds; Juliette Hussey Journal: Support Care Cancer Date: 2016-11-03 Impact factor: 3.603
Authors: N J O'Farrell; J V Reynolds; N Ravi; J O Larkin; V Malik; G F Wilson; C Muldoon; D O'Toole Journal: Ir J Med Sci Date: 2012-12-16 Impact factor: 1.568
Authors: Benjamin J Di Pardo; Nathan W Bronson; Brian S Diggs; Charles R Thomas; John G Hunter; James P Dolan Journal: World J Surg Date: 2016-02 Impact factor: 3.352